Antifibrotics modulate B lymphocyte activation resulting in a decrease of the profibrotic milieu in patients with pulmonary fibrosis

A. Egan (Rochester, United States of America), M. Ali (Rochester, United States of America), G. Shaughnessy (Rochester, United States of America), H. Dasari (Montreal, Canada), V. Van Keulen (Rochester, United States of America), T. Peikert (Rochester, United States of America), E. Carmona Porquera (Rochester, United States of America)

Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Session: Translational aspects of idiopathic interstitial pneumonia
Session type: Thematic Poster
Number: 1290
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Egan (Rochester, United States of America), M. Ali (Rochester, United States of America), G. Shaughnessy (Rochester, United States of America), H. Dasari (Montreal, Canada), V. Van Keulen (Rochester, United States of America), T. Peikert (Rochester, United States of America), E. Carmona Porquera (Rochester, United States of America). Antifibrotics modulate B lymphocyte activation resulting in a decrease of the profibrotic milieu in patients with pulmonary fibrosis. 1290

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
c-Met expression induction in immune cells modulates pulmonary fibrosis progression
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020

Altered expression of adhesion molecules in circulating neutrophils of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 479s
Year: 2002

Impaired lung function is associated with systemic inflammation and macrophage activation
Source: Eur Respir J 2015; 45: 557-559
Year: 2015


Treg alterations lead to systemic and local immune deregulation in idiopathic pulmonary fibrosis and collagen vascular disease-associated interstitial pneumonia
Source: Annual Congress 2007 - Cell biology of asthma and COPD
Year: 2007


Treg depletion reduces bleomycin-induced pulmonary fibrosis by inducing Th17 and other CD4+T cell subset responses in lung
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016

Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 17: 180-189
Year: 2001



The role of IL-10 receptors in aberrant homeostatic control of TNF-α in idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2002; 20: Suppl. 38, 599s
Year: 2002

Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells
Source: Annual Congress 2011 - T-cell subsets
Year: 2011

Corticosteroids inhibit perivascular recruitment of IL-6 producing cells, maintain BMPR-II pulmonary expression and prevent pulmonary hypertension in monocrotalin-exposed rats
Source: Eur Respir J 2007; 30: Suppl. 51, 347s
Year: 2007

CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages
Source: Eur Respir J, 51 (3) 1702120; 10.1183/13993003.02120-2017
Year: 2018



PP121 – Gaq/11 and Ga12/13 promote pulmonary fibrosis by driving distinct myofibroblast functions
Source: ERS Lung Science Conference 2021
Year: 2021

High expression of telomerase/endothelin-1 increase replication and activation of vascular myofibroblasts in usual interstitial pneumonia/idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010


The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats
Source: Eur Respir J 2002; 20: Suppl. 38, 487s
Year: 2002

Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function
Source: Eur Respir J 2006; 28: 113-122
Year: 2006



CCR7 deficiency induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010


Circulating MDSC modulate IPF progression by orchestrating immunosuppressive and pro-fibrotic networks
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018

NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009

Decreased apoptotic rate of alveolar macrophages of patients with idiopathic pulmonary fibrosis is not associated with difference in expression of fas or fas ligand
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008

Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 404s
Year: 2005